Psychemedics Corp
NASDAQ:PMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Psychemedics Corp
Cash from Investing Activities
Psychemedics Corp
Cash from Investing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Psychemedics Corp
NASDAQ:PMD
|
Cash from Investing Activities
$35k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Investing Activities
-$668m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-3%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Investing Activities
-$5.9B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
8%
|
|
|
Cigna Corp
NYSE:CI
|
Cash from Investing Activities
-$4.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Investing Activities
-$1.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
11%
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Cash from Investing Activities
-$627.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Psychemedics Corp
Glance View
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. The company is headquartered in Acton, Massachusetts and currently employs 139 full-time employees. The firm provides testing services for the detection of drugs of abuse through the analysis of hair samples. The Company’s testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The firm customize its enzyme immunoassay (EIA) procedures to drug test hair samples. The firm provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines, opiates, synthetic cannabinoids, benzodiazepines, nicotine and fentanyl. The firm markets its corporate drug testing services through its own sales force, distributors and webinars. The firm markets its home drug testing service, PDT-90, through the Internet.
See Also
What is Psychemedics Corp's Cash from Investing Activities?
Cash from Investing Activities
35k
USD
Based on the financial report for Sep 30, 2024, Psychemedics Corp's Cash from Investing Activities amounts to 35k USD.
